DFVX moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 15 of 17 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on DFVX as a result. In 43 of 52 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for DFVX just turned positive on October 06, 2026. Looking at past instances where DFVX's MACD turned positive, the stock continued to rise in 25 of 33 cases over the following month. The odds of a continued upward trend are 76%.
The 10-day moving average for DFVX crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +0.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where DFVX advanced for three days, in 189 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
DFVX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 22 of 41 cases where DFVX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DFVX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
The Aroon Indicator for DFVX entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Moving Average Convergence Divergence (MACD) for MS turned positive on October 21, 2026. Looking at past instances where MS's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MS's RSI Indicator exited the oversold zone, 14 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 58 cases where MS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +4.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in 231 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for MS entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.756) is normal, around the industry mean (3.638). P/E Ratio (14.961) is within average values for comparable stocks, (8.944). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.025) settles around the average of (7.191) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (16.763).
MS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 20 | |
SMR RATING 1..100 | 5 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 57 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DFVX | MS | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 70% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 72% |
| Momentum ODDS (%) | 2 days ago 83% | N/A |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 87% | 2 days ago 65% |
| Declines ODDS (%) | 30 days ago 53% | 4 days ago 60% |
| BollingerBands ODDS (%) | 7 days ago 79% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 57% | 2 days ago 54% |
A.I.dvisor indicates that over the last year, DFVX has been closely correlated with EMR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if DFVX jumps, then EMR could also see price increases.
| Ticker / NAME | Correlation To DFVX | 1D Price Change % | ||
|---|---|---|---|---|
| DFVX | 100% | +0.23% | ||
| EMR - DFVX | 67% Closely correlated | +1.65% | ||
| CCL - DFVX | 61% Loosely correlated | +0.89% | ||
| MS - DFVX | 61% Loosely correlated | +3.66% | ||
| GS - DFVX | 61% Loosely correlated | +2.25% | ||
| DAL - DFVX | 61% Loosely correlated | +1.32% | ||
More | ||||